Gary H Rabin Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Gary H Rabin.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Gary H Rabin. Gary H Rabin is CEO & CFO in Ocata Therapeutics, Inc. ($ACTC).
Latest Insider Trading Transactions of Gary H Rabin
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 15 2013 | ACTC | Ocata Therapeutics ... | Rabin Gary H | CEO & CFO | Sell | S | 0.08 | 1,000,000 | 79,200 | 6,000,001 | 7 M to 6 M (-14.29 %) |
| Apr 15 2013 | ACTC | Ocata Therapeutics ... | Rabin Gary H | CEO & CFO | Sell | S | 0.07 | 650,000 | 45,565 | 7,000,001 | 7.7 M to 7 M (-8.50 %) |
| Apr 15 2013 | ACTC | Ocata Therapeutics ... | Rabin Gary H | CEO & CFO | Sell | S | 0.07 | 350,000 | 25,025 | 7,650,001 | 8 M to 7.7 M (-4.37 %) |
| Apr 15 2013 | ACTC | Ocata Therapeutics ... | Rabin Gary H | CEO & CFO | Sell | S | 0.08 | 391,444 | 32,098 | 8,000,001 | 8.4 M to 8 M (-4.66 %) |
| Apr 15 2013 | ACTC | Ocata Therapeutics ... | Rabin Gary H | CEO & CFO | Sell | S | 0.08 | 608,556 | 50,023 | 8,391,445 | 9 M to 8.4 M (-6.76 %) |
| Apr 15 2013 | ACTC | Ocata Therapeutics ... | Rabin Gary H | CEO & CFO | Sell | S | 0.08 | 1,000,000 | 78,400 | 9,000,001 | 10 M to 9 M (-10.00 %) |
| Apr 15 2013 | ACTC | Ocata Therapeutics ... | Rabin Gary H | CEO & CFO | Sell | S | 0.07 | 350,000 | 25,375 | 10,000,001 | 10.4 M to 10 M (-3.38 %) |
| Apr 15 2013 | ACTC | Ocata Therapeutics ... | Rabin Gary H | CEO & CFO | Sell | S | 0.08 | 24,500 | 1,960 | 10,350,001 | 10.4 M to 10.4 M (-0.24 %) |
| Apr 15 2013 | ACTC | Ocata Therapeutics ... | Rabin Gary H | CEO & CFO | Sell | S | 0.08 | 80,000 | 6,440 | 10,374,501 | 10.5 M to 10.4 M (-0.77 %) |
| Apr 15 2013 | ACTC | Ocata Therapeutics ... | Rabin Gary H | CEO & CFO | Sell | S | 0.08 | 95,471 | 7,666 | 10,454,501 | 10.5 M to 10.5 M (-0.90 %) |
| Apr 15 2013 | ACTC | Ocata Therapeutics ... | Rabin Gary H | CEO & CFO | Sell | S | 0.07 | 388,090 | 26,584 | 10,549,972 | 10.9 M to 10.5 M (-3.55 %) |
| Apr 15 2013 | ACTC | Ocata Therapeutics ... | Rabin Gary H | CEO & CFO | Sell | S | 0.07 | 290,000 | 20,793 | 10,938,062 | 11.2 M to 10.9 M (-2.58 %) |
| Apr 15 2013 | ACTC | Ocata Therapeutics ... | Rabin Gary H | CEO & CFO | Sell | S | 0.08 | 122,000 | 9,821 | 11,228,062 | 11.4 M to 11.2 M (-1.07 %) |
| Apr 15 2013 | ACTC | Ocata Therapeutics ... | Rabin Gary H | CEO & CFO | Sell | S | 0.08 | 199,910 | 16,653 | 11,350,062 | 11.5 M to 11.4 M (-1.73 %) |
| Apr 15 2013 | ACTC | Ocata Therapeutics ... | Rabin Gary H | CEO & CFO | Sell | S | 0.18 | 625,000 | 109,500 | 11,549,972 | 12.2 M to 11.5 M (-5.13 %) |
| Apr 15 2013 | ACTC | Ocata Therapeutics ... | Rabin Gary H | CEO & CFO | Sell | S | 0.14 | 720,920 | 104,389 | 12,174,972 | 12.9 M to 12.2 M (-5.59 %) |
| Apr 15 2013 | ACTC | Ocata Therapeutics ... | Rabin Gary H | CEO & CFO | Sell | S | 0.14 | 787,429 | 111,657 | 12,895,892 | 13.7 M to 12.9 M (-5.75 %) |
| Apr 15 2013 | ACTC | Ocata Therapeutics ... | Rabin Gary H | CEO & CFO | Sell | S | 0.15 | 491,650 | 71,388 | 13,683,321 | 14.2 M to 13.7 M (-3.47 %) |
| Apr 15 2013 | ACTC | Ocata Therapeutics ... | Rabin Gary H | CEO & CFO | Sell | S | 0.17 | 539,987 | 91,690 | 14,174,971 | 14.7 M to 14.2 M (-3.67 %) |
| Apr 15 2013 | ACTC | Ocata Therapeutics ... | Rabin Gary H | CEO & CFO | Sell | S | 0.16 | 707,913 | 115,956 | 14,714,958 | 15.4 M to 14.7 M (-4.59 %) |
| Apr 15 2013 | ACTC | Ocata Therapeutics ... | Rabin Gary H | CEO & CFO | Sell | S | 0.16 | 135,100 | 21,940 | 15,422,871 | 15.6 M to 15.4 M (-0.87 %) |
| Apr 15 2013 | ACTC | Ocata Therapeutics ... | Rabin Gary H | CEO & CFO | Sell | S | 0.17 | 667,000 | 110,322 | 15,557,971 | 16.2 M to 15.6 M (-4.11 %) |
| Apr 15 2013 | ACTC | Ocata Therapeutics ... | Rabin Gary H | CEO & CFO | Sell | S | 0.19 | 266,898 | 51,938 | 16,224,971 | 16.5 M to 16.2 M (-1.62 %) |
| Apr 15 2013 | ACTC | Ocata Therapeutics ... | Rabin Gary H | CEO & CFO | Sell | S | 0.18 | 733,102 | 130,126 | 16,491,869 | 17.2 M to 16.5 M (-4.26 %) |
| Apr 15 2013 | ACTC | Ocata Therapeutics ... | Rabin Gary H | CEO & CFO | Sell | S | 0.17 | 390,993 | 68,072 | 17,224,971 | 17.6 M to 17.2 M (-2.22 %) |
| Apr 15 2013 | ACTC | Ocata Therapeutics ... | Rabin Gary H | CEO & CFO | Sell | S | 0.19 | 250,000 | 47,225 | 17,615,964 | 17.9 M to 17.6 M (-1.40 %) |
| Apr 15 2013 | ACTC | Ocata Therapeutics ... | Rabin Gary H | CEO & CFO | Sell | S | 0.19 | 250,000 | 48,700 | 17,865,964 | 18.1 M to 17.9 M (-1.38 %) |
Page: 1